Zacks Company Profile for Bio-Rad Laboratories, Inc. (BIO.B : NYSE) |
|
|
|
Company Description |
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Number of Employees: |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $505.00 |
Daily Weekly Monthly
 |
20 Day Moving Average: 193 shares |
Shares Outstanding: 29.94 (millions) |
Market Capitalization: $15,120.51 (millions) |
Beta: 0.78 |
52 Week High: $818.60 |
52 Week Low: $504.50 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-8.53% |
0.23% |
12 Week |
-20.96% |
-14.24% |
Year To Date |
-30.14% |
-16.93% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Norman Schwartz - Chief Executive Officer and Chairman
Norman Schwartz - President and Director
Ilan Daskal - Senior Vice President and Chief Accounting Officer
Christine A. Tsingos - Vice President;Chief Financial Officer
Ajit Ramalingam - Senior Vice President and Chief Accounting Officer
|
|
Peer Information
Bio-Rad Laboratories, Inc. (CORR.)
Bio-Rad Laboratories, Inc. (RSPI)
Bio-Rad Laboratories, Inc. (CGXP)
Bio-Rad Laboratories, Inc. (BGEN)
Bio-Rad Laboratories, Inc. (GTBP)
Bio-Rad Laboratories, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090572108
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
|
|
Share - Related Items
Shares Outstanding: 29.94
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.78
Market Capitalization: $15,120.51 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/04/22 |
|
|
|
|